Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9023 |
High Similarity |
NPD3027 |
Phase 3 |
0.8686 |
High Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8686 |
High Similarity |
NPD1613 |
Approved |
0.8593 |
High Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8529 |
High Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8523 |
High Similarity |
NPD37 |
Approved |
0.8487 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.8417 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.8417 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.8355 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.8355 |
Intermediate Similarity |
NPD4966 |
Approved |
0.8355 |
Intermediate Similarity |
NPD4965 |
Approved |
0.8273 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8261 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.8228 |
Intermediate Similarity |
NPD7228 |
Approved |
0.8116 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.8082 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.8071 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.8058 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.8015 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.8014 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7975 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7937 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7911 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7899 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7899 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7899 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7879 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7838 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7826 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7806 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7778 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7771 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.777 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7764 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7764 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7764 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7756 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.773 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7727 |
Intermediate Similarity |
NPD228 |
Approved |
0.7727 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7721 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7702 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7697 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7676 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7662 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7643 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7626 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7576 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7576 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7535 |
Intermediate Similarity |
NPD3094 |
Phase 2 |
0.7532 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7518 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7483 |
Intermediate Similarity |
NPD3657 |
Discovery |
0.747 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7467 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7467 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.7456 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7455 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7452 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7444 |
Intermediate Similarity |
NPD4750 |
Phase 3 |
0.7438 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7432 |
Intermediate Similarity |
NPD4097 |
Suspended |
0.741 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7403 |
Intermediate Similarity |
NPD1511 |
Approved |
0.74 |
Intermediate Similarity |
NPD3539 |
Phase 1 |
0.74 |
Intermediate Similarity |
NPD6099 |
Approved |
0.74 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7386 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7376 |
Intermediate Similarity |
NPD3092 |
Approved |
0.7375 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7368 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7365 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7362 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7355 |
Intermediate Similarity |
NPD4160 |
Clinical (unspecified phase) |
0.7351 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7351 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7351 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7345 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7343 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7321 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.732 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.731 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7308 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7297 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.7284 |
Intermediate Similarity |
NPD4055 |
Discovery |
0.7267 |
Intermediate Similarity |
NPD4663 |
Approved |
0.7251 |
Intermediate Similarity |
NPD8054 |
Approved |
0.7251 |
Intermediate Similarity |
NPD8053 |
Approved |
0.7246 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7244 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7241 |
Intermediate Similarity |
NPD4624 |
Approved |
0.7234 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7229 |
Intermediate Similarity |
NPD27 |
Approved |
0.7229 |
Intermediate Similarity |
NPD2489 |
Approved |
0.7226 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.7225 |
Intermediate Similarity |
NPD7906 |
Approved |
0.7222 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7219 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7214 |
Intermediate Similarity |
NPD3091 |
Approved |
0.7212 |
Intermediate Similarity |
NPD3051 |
Approved |
0.7208 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7205 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7197 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7197 |
Intermediate Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.7195 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7193 |
Intermediate Similarity |
NPD4577 |
Approved |
0.7193 |
Intermediate Similarity |
NPD4578 |
Approved |
0.719 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7182 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7181 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7181 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7179 |
Intermediate Similarity |
NPD7041 |
Phase 2 |
0.7179 |
Intermediate Similarity |
NPD7040 |
Clinical (unspecified phase) |
0.7176 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7169 |
Intermediate Similarity |
NPD2970 |
Approved |
0.7169 |
Intermediate Similarity |
NPD2969 |
Approved |
0.7162 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7162 |
Intermediate Similarity |
NPD5109 |
Approved |
0.7162 |
Intermediate Similarity |
NPD5110 |
Phase 2 |
0.7162 |
Intermediate Similarity |
NPD5111 |
Phase 2 |
0.7161 |
Intermediate Similarity |
NPD5241 |
Discontinued |
0.7161 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7161 |
Intermediate Similarity |
NPD2677 |
Approved |
0.716 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7153 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7153 |
Intermediate Similarity |
NPD5327 |
Phase 3 |
0.7152 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7152 |
Intermediate Similarity |
NPD6111 |
Discontinued |
0.7152 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7152 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7152 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD3060 |
Approved |
0.7135 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7135 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7134 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7134 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7134 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7134 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7133 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7133 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7133 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7125 |
Intermediate Similarity |
NPD4678 |
Approved |
0.7125 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7111 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7108 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7105 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7097 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7093 |
Intermediate Similarity |
NPD7311 |
Approved |
0.7093 |
Intermediate Similarity |
NPD7310 |
Approved |
0.7093 |
Intermediate Similarity |
NPD7313 |
Approved |
0.7093 |
Intermediate Similarity |
NPD7312 |
Approved |
0.7086 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7081 |
Intermediate Similarity |
NPD5090 |
Approved |
0.7081 |
Intermediate Similarity |
NPD5089 |
Approved |
0.7076 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7073 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7073 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.707 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.707 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.707 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.707 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.7052 |
Intermediate Similarity |
NPD7309 |
Approved |
0.7051 |
Intermediate Similarity |
NPD2219 |
Phase 1 |
0.7045 |
Intermediate Similarity |
NPD940 |
Approved |
0.7045 |
Intermediate Similarity |
NPD846 |
Approved |
0.7042 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7042 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7032 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7029 |
Intermediate Similarity |
NPD7635 |
Approved |
0.7025 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7021 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.702 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7014 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7007 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7006 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD6671 |
Approved |
0.6993 |
Remote Similarity |
NPD5960 |
Phase 3 |
0.6993 |
Remote Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.6993 |
Remote Similarity |
NPD5588 |
Approved |
0.6993 |
Remote Similarity |
NPD5126 |
Approved |
0.6993 |
Remote Similarity |
NPD6516 |
Phase 2 |
0.6993 |
Remote Similarity |
NPD5125 |
Phase 3 |
0.6993 |
Remote Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.6993 |
Remote Similarity |
NPD3095 |
Discontinued |
0.6993 |
Remote Similarity |
NPD5846 |
Approved |
0.6987 |
Remote Similarity |
NPD6331 |
Phase 2 |
0.6987 |
Remote Similarity |
NPD8166 |
Discontinued |
0.6986 |
Remote Similarity |
NPD1283 |
Approved |
0.698 |
Remote Similarity |
NPD7095 |
Approved |
0.6974 |
Remote Similarity |
NPD1607 |
Approved |
0.6974 |
Remote Similarity |
NPD6353 |
Approved |
0.697
|
Remote Similarity |
NPD7832 |
Clinical (unspecified phase) |